Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998598404> ?p ?o ?g. }
- W1998598404 endingPage "568" @default.
- W1998598404 startingPage "554" @default.
- W1998598404 abstract "Aspirin gained tremendous popularity during the 1918 Spanish Influenza virus pandemic, 50 years prior to the demonstration of their inhibitory action on prostaglandins. Here, we show that during influenza A virus (IAV) infection, prostaglandin E2 (PGE2) was upregulated, which led to the inhibition of type I interferon (IFN) production and apoptosis in macrophages, thereby causing an increase in virus replication. This inhibitory role of PGE2 was not limited to innate immunity, because both antigen presentation and T cell mediated immunity were also suppressed. Targeted PGE2 suppression via genetic ablation of microsomal prostaglandin E-synthase 1 (mPGES-1) or by the pharmacological inhibition of PGE2 receptors EP2 and EP4 substantially improved survival against lethal IAV infection whereas PGE2 administration reversed this phenotype. These data demonstrate that the mPGES-1-PGE2 pathway is targeted by IAV to evade host type I IFN-dependent antiviral immunity. We propose that specific inhibition of PGE2 signaling might serve as a treatment for IAV." @default.
- W1998598404 created "2016-06-24" @default.
- W1998598404 creator A5004310895 @default.
- W1998598404 creator A5009030222 @default.
- W1998598404 creator A5012612103 @default.
- W1998598404 creator A5019495500 @default.
- W1998598404 creator A5022704926 @default.
- W1998598404 creator A5038289493 @default.
- W1998598404 creator A5039154297 @default.
- W1998598404 creator A5051652706 @default.
- W1998598404 creator A5052174808 @default.
- W1998598404 creator A5059371770 @default.
- W1998598404 creator A5060581591 @default.
- W1998598404 creator A5072686480 @default.
- W1998598404 creator A5074602745 @default.
- W1998598404 creator A5091615631 @default.
- W1998598404 date "2014-04-01" @default.
- W1998598404 modified "2023-10-15" @default.
- W1998598404 title "Targeted Prostaglandin E2 Inhibition Enhances Antiviral Immunity through Induction of Type I Interferon and Apoptosis in Macrophages" @default.
- W1998598404 cites W1561591381 @default.
- W1998598404 cites W1562280973 @default.
- W1998598404 cites W1642748179 @default.
- W1998598404 cites W1826726928 @default.
- W1998598404 cites W1940294549 @default.
- W1998598404 cites W1964464231 @default.
- W1998598404 cites W1965916060 @default.
- W1998598404 cites W1972038858 @default.
- W1998598404 cites W1978706284 @default.
- W1998598404 cites W1980495472 @default.
- W1998598404 cites W1998846885 @default.
- W1998598404 cites W2002406225 @default.
- W1998598404 cites W2025648442 @default.
- W1998598404 cites W2027397519 @default.
- W1998598404 cites W2029184645 @default.
- W1998598404 cites W2032969319 @default.
- W1998598404 cites W2047948762 @default.
- W1998598404 cites W2050084139 @default.
- W1998598404 cites W2053425043 @default.
- W1998598404 cites W2069509021 @default.
- W1998598404 cites W2080503511 @default.
- W1998598404 cites W2083437974 @default.
- W1998598404 cites W2093631337 @default.
- W1998598404 cites W2096241508 @default.
- W1998598404 cites W2100796791 @default.
- W1998598404 cites W2103457670 @default.
- W1998598404 cites W2105622887 @default.
- W1998598404 cites W2106353836 @default.
- W1998598404 cites W2106377620 @default.
- W1998598404 cites W2107447190 @default.
- W1998598404 cites W2113712662 @default.
- W1998598404 cites W2114629038 @default.
- W1998598404 cites W2129935236 @default.
- W1998598404 cites W2131683624 @default.
- W1998598404 cites W2135319721 @default.
- W1998598404 cites W2142939744 @default.
- W1998598404 cites W2150658610 @default.
- W1998598404 cites W2155470315 @default.
- W1998598404 cites W2158668374 @default.
- W1998598404 cites W2161023527 @default.
- W1998598404 cites W2161740453 @default.
- W1998598404 cites W2162392926 @default.
- W1998598404 cites W2170851221 @default.
- W1998598404 cites W2171416397 @default.
- W1998598404 cites W4240658254 @default.
- W1998598404 doi "https://doi.org/10.1016/j.immuni.2014.02.013" @default.
- W1998598404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24726877" @default.
- W1998598404 hasPublicationYear "2014" @default.
- W1998598404 type Work @default.
- W1998598404 sameAs 1998598404 @default.
- W1998598404 citedByCount "164" @default.
- W1998598404 countsByYear W19985984042014 @default.
- W1998598404 countsByYear W19985984042015 @default.
- W1998598404 countsByYear W19985984042016 @default.
- W1998598404 countsByYear W19985984042017 @default.
- W1998598404 countsByYear W19985984042018 @default.
- W1998598404 countsByYear W19985984042019 @default.
- W1998598404 countsByYear W19985984042020 @default.
- W1998598404 countsByYear W19985984042021 @default.
- W1998598404 countsByYear W19985984042022 @default.
- W1998598404 countsByYear W19985984042023 @default.
- W1998598404 crossrefType "journal-article" @default.
- W1998598404 hasAuthorship W1998598404A5004310895 @default.
- W1998598404 hasAuthorship W1998598404A5009030222 @default.
- W1998598404 hasAuthorship W1998598404A5012612103 @default.
- W1998598404 hasAuthorship W1998598404A5019495500 @default.
- W1998598404 hasAuthorship W1998598404A5022704926 @default.
- W1998598404 hasAuthorship W1998598404A5038289493 @default.
- W1998598404 hasAuthorship W1998598404A5039154297 @default.
- W1998598404 hasAuthorship W1998598404A5051652706 @default.
- W1998598404 hasAuthorship W1998598404A5052174808 @default.
- W1998598404 hasAuthorship W1998598404A5059371770 @default.
- W1998598404 hasAuthorship W1998598404A5060581591 @default.
- W1998598404 hasAuthorship W1998598404A5072686480 @default.
- W1998598404 hasAuthorship W1998598404A5074602745 @default.
- W1998598404 hasAuthorship W1998598404A5091615631 @default.
- W1998598404 hasBestOaLocation W19985984041 @default.
- W1998598404 hasConcept C134018914 @default.
- W1998598404 hasConcept C136449434 @default.